gene expression analysis
CareDx Stock Rises Following American Society of Transplant Surgeons' Position Statement on Test Use
ASTS supports the use of dd-cfDNA as a biomarker of kidney transplant rejection, as well as peripheral blood gene expression profiling to help rule out heart transplant rejection.
Ampel will use the signature to develop FibroGene, a fibromyalgia blood test that the company expects to launch next year.
The company is developing a nonsurgical approach to help increase testing rates and lower the time to diagnosis for endometriosis.
Prostatype Genomics, Life Genomics Ink Commercialization Deal for Prostate Cancer Test
Prostatype's test is designed to use gene expression and certain clinical measures to determine a prostate tumor's aggressiveness and guide treatment.
The privately held company is coupling gene expression tests with analysis to produce clinical decision support as it expands beyond its historic focus on pharma.
Apr 25, 2022
Feb 24, 2022
Mar 18, 2021
Nov 9, 2020
Castle Biosciences Q3 Revenues Up 3 Percent
Jan 10, 2020